New potential of ACE inhibitors in clinical practice

New potential of ACE inhibitors in clinical practice

The paper reviews the results of the studies demonstrating new potential of ACE inhibitors. The traditional clinical niche for ACE inhibitor therapy (arterial hypertension, heart failure, diabetic nephropathy) has been extended recently. Substantial vasoprotective effect of these medications has an...

Full description

Bibliographic Details
Main Authors:	D. V. Nebieridze, A. S. Safaryan
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ингибиторы ангиотензин-превращающего фермента заболевания атеросклеротического генеза улучшение прогноза класс-эффект ингибиторов ангиотензин-превращающего фермента
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2129

Similar Items

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitor cilazapril: its place in cardiovascular diseases treatment
by: G. A. Baryshnikova
Published: (2005-08-01)

Levels of cytokines and C-reactive protein as treatment effectiveness criteria in patients with coronary heart disease and chronic heart failure
by: E. Yu. Sazhina, et al.
Published: (2008-06-01)

Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)

PRESTIGE study: ACE inhibitors efficacy in patients with acute myocardial infarction and left ventricular dysfunction
by: Yu. N. Belenkov, et al.
Published: (2005-04-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Perindopril arginine: a new ACE inhibitor salt increases therapeutic potential
by: Yu. A. Karpov
Published: (2008-12-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

New perspectives in coronary heart disease management
by: V. I. Makolkin
Published: (2005-02-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

Inflammation role in atrial fibrillation pathogenesis
by: A. I. Tarzimanova, et al.
Published: (1970-01-01)

Endothelial dysfunction in arterial hypertension - cardiovascular complication risk factor
by: B. A. Namakanov, et al.
Published: (2005-12-01)

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW
by: S. R. Gilyarevskiy, et al.
Published: (2016-01-01)

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
by: T. V. Aparina, et al.
Published: (2005-06-01)

Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
by: V. I. Makolkin
Published: (2010-08-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure
by: I. E. Chazova, et al.
Published: (2007-02-01)

ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ
Published: (2016-12-01)

ASSOCIATION BETWEEN ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY, BONE MASS, AND OSTEOPOROSIS RISK FACTORS
by: K. E. Sobchenko, et al.
Published: (2013-10-01)

Heart diastolic dysfunction in patients with familial arterial hypertension
by: B. A. Namakanov, et al.
Published: (2005-06-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОЙ КОРРЕКЦИИ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА В ИНТРАОПЕРАЦИОННОМ И РАННЕМ ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ ПОСЛЕ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
by: R. E. Yakubtsevich, et al.
Published: (2022-03-01)

Vliyanie polimorfizma gena angiotenzin-I-prevrashchayushchego fermenta (APF) na antiproteinuricheskiy effekt ingibitorov APF u molodykh bol'nykh insulinzavisimym sakharnym diabetom
by: G I Sivous, et al.
Published: (1998-03-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Calcium-Phosphate Nanoparticles — a System for Drug Delivery to the Anterior Eye Chamber
by: O. V. Beznos, et al.
Published: (2021-07-01)

COMBINATION ANTIHYPERTENSIVE THERAPY: WHEN THE WHOLE IS GREATER THAN THE SUM OF ITS PARTS
by: E. O. Taratukhin, et al.
Published: (2013-06-01)

VESSEL WALL STIFFNESS IN ARTERIAL HYPERTENSION AND OPPORTUNITIES FOR ITS MODULATION
by: L. L. Kirichenko, et al.
Published: (2016-12-01)

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: K. A. Gyamdzhyan, et al.
Published: (2015-12-01)

Enalapril effects on renal function and ACE gene polymorphism in hypertensive nephropathy
by: K. Y. Zholdoshov, et al.
Published: (2010-10-01)

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)